AU2003267532A1 - PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES - Google Patents

PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES

Info

Publication number
AU2003267532A1
AU2003267532A1 AU2003267532A AU2003267532A AU2003267532A1 AU 2003267532 A1 AU2003267532 A1 AU 2003267532A1 AU 2003267532 A AU2003267532 A AU 2003267532A AU 2003267532 A AU2003267532 A AU 2003267532A AU 2003267532 A1 AU2003267532 A1 AU 2003267532A1
Authority
AU
Australia
Prior art keywords
synuclein
peptides
alpha
treatment
related diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003267532A
Inventor
David Allsop
Omar M. A. El-Agnaf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lancaster University
Original Assignee
Lancaster University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lancaster University filed Critical Lancaster University
Publication of AU2003267532A1 publication Critical patent/AU2003267532A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003267532A 2002-07-22 2003-07-22 PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES Abandoned AU2003267532A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0216972A GB0216972D0 (en) 2002-07-22 2002-07-22 Peptides and peptide derivaties for the treatment of &-synuclein-related diseases
GB0216972.0 2002-07-22
PCT/GB2003/003240 WO2004009625A2 (en) 2002-07-22 2003-07-22 PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF α-SYNUCLEIN-RELATED DISEASES

Publications (1)

Publication Number Publication Date
AU2003267532A1 true AU2003267532A1 (en) 2004-02-09

Family

ID=9940894

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003267532A Abandoned AU2003267532A1 (en) 2002-07-22 2003-07-22 PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES

Country Status (3)

Country Link
AU (1) AU2003267532A1 (en)
GB (1) GB0216972D0 (en)
WO (1) WO2004009625A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080014194A1 (en) 2003-10-31 2008-01-17 Elan Pharmaceuticals, Inc. Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
US8697082B2 (en) 2002-11-01 2014-04-15 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US9034337B2 (en) 2003-10-31 2015-05-19 Prothena Biosciences Limited Treatment and delay of outset of synucleinopathic and amyloidogenic disease
TW200509968A (en) 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
US7358331B2 (en) 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
US7674599B2 (en) 2003-11-08 2010-03-09 Elan Pharmaceuticals, Inc. Methods of using antibodies to detect alpha-synuclein in fluid samples
WO2007071789A1 (en) * 2005-12-22 2007-06-28 Vib Vzw Means and methods for mediating protein interference
US8147833B2 (en) 2007-02-23 2012-04-03 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
JP5558834B2 (en) 2007-02-23 2014-07-23 ヤンセン アルツハイマー イミュノセラピー Prevention and treatment of synucleinopathies and amyloidogenic diseases
GB0716885D0 (en) * 2007-08-30 2007-10-10 United Arab Emirates Universit Diagnostic agent
AT506535B1 (en) 2008-02-22 2010-04-15 Affiris Forschungs & Entwicklungs Gmbh VACCINE CONTAINING ALPHA SYNUCLEIN MIMOTOPES BASED ON PEPTIDES
NZ589302A (en) 2008-04-17 2012-11-30 Declion Pharmaceuticals Inc Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
KR102554448B1 (en) * 2016-06-29 2023-07-11 더 리전츠 오브 더 유니버시티 오브 캘리포니아 Structure-Based Peptide Inhibitors of Alpha-Synuclein Aggregation
CN106854233B (en) * 2017-03-03 2020-07-17 国家纳米科学中心 Quasi-peptide and preparation method and application thereof
WO2019058389A1 (en) 2017-09-20 2019-03-28 Council Of Scientific And Industrial Research Potent peptide inhibitors of protein aggregation
CN113727701B (en) * 2019-03-28 2023-11-28 香港中文大学 SUMO peptides for the treatment of neurodegenerative diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001271865C1 (en) * 2000-07-07 2006-12-07 Panacea Pharmaceuticals, Inc. Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases

Also Published As

Publication number Publication date
GB0216972D0 (en) 2002-08-28
WO2004009625A2 (en) 2004-01-29
WO2004009625A3 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
AU2003220317A1 (en) Methods and drug delivery systems for the treatment of orofacial diseases
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
AU2003267829A1 (en) Peptides and methods for the control of obesity
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003222347A1 (en) Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003267532A1 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES
AU2002346504A1 (en) Therapeutic protein and treatments
AU2003289742A1 (en) Stable therapeutic proteins
AU2003298911A1 (en) Cyclosporins for the treatment of autoimmune diseases
AU2003295343A1 (en) Uses of human zven proteins and polynucleotides
AU2003238039A1 (en) Nasal peptide pharmaceutical formulation
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003290886A1 (en) Modified alpha-msh peptides and derivatives thereof
AU2003221096A1 (en) Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003252075A1 (en) Human immunosuppressive protein
AU2003269153A1 (en) Rfamide-related peptide precursor proteins and rfamide peptides
GB0201025D0 (en) The treatment of degenerative diseases
AU2003238281A1 (en) Two synthetic peptides for treatment and prevention of cancers
AU2002364757A1 (en) Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
AU2003215384A1 (en) Microdispersion treatment of a protein or pharmaceutical
AU2003258550A1 (en) Splicing-variant of the human p53 protein and use thereof in the production of pharmaceutical preparations for treating tumoural diseases
AU2003288127A1 (en) DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase